A rapid, high-capacity assay for evaluating the potency of anti-HIV compounds was devised. This assay measures cell associated viral RNA levels 3 days after infection of susceptiblf T-cell lines grown in individual microtitre plate~1Is. Viral RNA was quantified by a sandwich hybridization assay, the first step of which was performed directly in crude infected cell Iysates prepared in guanidinium lsothlocyanate. Levels of cell-associated viral RNA were shown to correlate with the yield of infectious virus and this correlation formed the basis of the test. Antiviral potencies of a large series of compounds tested in this RNA hybridization assay correlated closely with potency values determined by a sensitive but slower and more labour-intensive yieldreduction assay. Both laboratory strains and selected clinical isolates of HIV can be detected in this RNA hybridization assay. Received
Introduction
An essential element in the discovery and development of antiviral drugs is the ability to quantitatively measure antiviral effects of compounds in cell culture systems. In the case of Human Immunodeficiency Virus type 1 (HIV-1), a variety of infectiVity assays has been developed to measure virus replication. Assays based on quantification of viral reverse transcriptase activity or p24 antigen have been used widely. Frequently, such measurements of the expression of viral protein products are coupled with end point dilutions of infecting virus in order to calculate a tissue culture infectious dose for each virus sample. The cytopathic effects of HIV infection on certain host cell types have provided a basis for infectivity assays based on cell killing, or the induction of syncytia in infected cultures. An early assay employed for the rapid evaluation of the anti-HIV potency of test compounds was based on the protection of infected MT-2 or MT-4 cells from HIVinduced cell death (Mitsuya and Broder,1986 ) Such cell protection could be quantified by the use of tetrazolium dye reduction assays (Mosmann, 1983; Alley et al.,1986; Pauwels et sl., 1988) , or fluorogenic dye uptake . Several plaque assays for HIV based on infection of artificially created monolayers of MT-2 or MT-4 cells have been devised (Harada et el., 1985; Nakashima et et., 1989; Smallheer et sl., 1992) . HIV infection of these highly susceptible cell lines led to the formation of foci of syncytia that could be visualized following neutral red or MIT staining. Alternatively, CD4expressing HeLa cell lines were generated which can be infected with HIV and which form the basis of focus forming assays detected by histological staining (Larder et et., 1989) , immunochemical staining (Chesebro and Wehrly, 1988; Pincus et el., 1991) , or activation of an integrated HIV LTR-p-galactosidase construct (Kimpton and Emerman, 1992) . Nara et al. (1988) used selected strains of CEM cells as the basis of a syncytia formation assay.
Quantification of HIV RNA might serve as a more direct measure of the extent of virus replication than either individual protein components of the virus or cytopathic effects in host cells. One potential advantage of measuring HIV RNA rather than p24 antigen or reverse transcriptase activity is the direct detection and quantification of genomic copies of the virus, rather than protein products of this genome, or the even more indirect effects of virus infection on host cell function and viability. The levels of viral RNA achieved in acutely infected cells can be quite high. For example, Somasundaran and Robinson (Samasundaran and Robinson, 1988; Robinson and Somasundaran, 1990) reported that the C8166 HTLV-t-transformed human T-cell line, which is highly susceptible to HIV infection, accumulated up to 40000 copies of HIV RNA per cell following acute infection. Gillespie et al. (1989) described the use of a magnetic particle-based nucleic acid sandwich hybridization assay to detect HIV RNA in Iysates of infected cells or virions. Japour et al. (1991) used this assay to study the response of AZT susceptible and -resistant viruses to AZT chemotherapy. Another advantage in using oligonucleotide-based nucleic acid hybridization assays is the relative ease of ---_./ Fig. 1 . Complex detected in HIV RNA Assay. The immobilized complex formed between HIV RNA, biotinylated capture oligonucleotide (B) and alkaline phosphatase-conjugated reporter oligonucelotide (AP) is depicted. This complex is expected to form following capture probe hybridization in solution, binding to streptavidin-coated wells, and secondary hybridization with alkaline phosphatase conjugated reporter probe. Immobilized alkaline phosphatase can be detected by the addition of MUBP, a f1u6rogenic substrate for alkaline phosphatase. preparation of a wide variety of probes complementary to known sequences of HIV genomes, although the broad sequence diversity among HIV strains suggests that oligonucleotide probes should be generated against relatively conserved regions of the genome if recognition of multiple strains, including clinical isolates, is desired.
In this paper a microtitre plate based method for evaluating the antiviral efficacy of compounds based on quantification of HIV RNA accumulation in acutely infected cells is described. pDAB 72 RNA with a signal to noise ratio of 2, while the sensitivity of the pol probes under the same conditions was 1.0 ng. As each probe set was able to detect in vitro HIV RNA transcripts, their ability to detect HIV RNA in infected ceillysates was then tested. Figure 3 shows the results of HIV RNA assays on samples collected at 24,48, and 72 h after HIV-1(RF) infection of MT-2 cells (grown in T-75 flasks) at various multiplicities of infection. Pelleted cells were lysed in 5 M GED, and the lysates assayed using pol probes. The results showed modest levels of HIV pol RNA at 24 h after infection at high virus concentration (2-4 TC1D socell-1 ) . HIV pol RNA was detected in all infected cultures by 48 h after infection and further increases were found at 72 h. Cultures infected at high virus concentrations (2-4 TCID socell-1 ) had lower levels of RNA after 72 h than those initially infected at lower concentrations of virus (0.5-1.0 TCID socell-1 ) . Also observed was a decrease in cell number 48 and 72 h after infection at high virus concentration. The reduction in RNA signal was due probably to Hlv-lnduced cell death of the highly susceptible MT-2 cells at these high virus concentrations. The signal generated from Iysates of uninfected MT-2 cells was negligible, <2-fold higher than reagent background. Thus, the HIV pol probes did not react with either cellular sequences or Ng in vitro RNA transcript Fig.2 . Detection of HIV in vitro RNA transcripts. Purified in vitro RNA transcripts of the pDAB 72 plasmid were added to 5 M GED and gagor po/biotinylated capture probes. Hybridization and detection of HIV RNA was performed as described in Materials and Experimental procedures. Lysates equivalent to 3 x 10 5 uninfected MT-2 cells, prepared in bulk in 5 M GED, were added to some hybridization reactions along with biotinylated capture probes. In the insert, the scale for HIV RNA(S/N) is expanded, to demonstrate the detection of low levels of HIV RNA.
Detection of viral RNA in infected cetrlysates

Results
Detection of in vitro RNA transcripts with gag and pol probes
The concept of capturing target nucleic acid on a solid phase by means of hybridization to a capture probe and detection of the captured complex by a second probe was described originally by Dunn and Hassell (1977) . Figure 1 illustrates the immobilized complex formed in the assay format between target RNA, reporter probe, capture probe, and the streptavidin-coated plate. As shown, unhybridized capture probe is bound also to streptavidin. A modified version of this HIV sandwich-hybridization assay has been described previously (Whetsell et al., 1992) .
Initial experiments tested the sensitivity of the probes used in the assay. Using RNA transcripts generated in vitro from plasmid pDAB72 containing portions of the gag and pol sequences of HIV (Erickson-Viitanen et al., 1989) , the gag probes produced 8-10 fold more signal than did the pol probes (Fig. 2) . The signal produced by both sets of probes was reduced 7-10 fold by the inclusion of lysate from 3 x 10 s uninfected MT-2 cells. After 5.5 h of signal development in the presence of cell lysate, the gag probes detected 0.3 ng or approximately 6 x 10 7 copies of MT-2 cells (5 x 10 5 cells per ml) were infected with dilutions of HIV-1 (RF) virus. Cells were pelleted and resuspended in fresh medium without virus after 6 h. At 24, 48, and 72 h after infection, total cell numbers were determined and cells from 20 ml aliquots were pelleted and lysed in 1 ml of 5M GED. Of this lysate, 20 III aliquots corresponding tp 0.4 ml of original culture, were assayed for HIV RNA sequences uSinQlPolprobes.
jiw ith HTLV-1 RNAs expressed in this HTLV-1 transformed cell line. Similar lack of hybridization with Iysates of uninfected MT-2 cells was seen for the HIV gag probes.
Adaptation of virus culture and sample processing to a micro titre plate format That it was possible to detect a significant HIV RNA signal from cells originally grown in 400 ul suggested that it should be possible to carry out the virus infection and sample lysis procedures directly in microtitre plates, as well as performing the quantitative HIV RNA assay in microtitre plates. By culturinq the MT2 cells in U bottom microtitre wells, it was possible to remove most of the tissue culture media without disturbing the cells at the bottom of the wells. Lysis, by addition of 5 M GED and biotinylated capture 'probe, and overnight hybridization were carried out in the initial culture wells. After dilution, each sample was transferred to a streptavidin coated plate. The use of a Cetus ProPette facilitated these dilution and transfer steps. Use of a biotin free medium (either a custom formulated RPMI without biotin [Gibco] or Dulbecco's Modified Eagle's medium) was found to be essential when culture medium remained with the cells. The 25 ul of RPMI cell culture medium included in the cell lysate prepared in microplate wells contributed approximately 20 pmoles of biotin to the final hybridization solution as compared to 3 pmoles of biotinylated capture probe present in the same solution. This excess of free biotin reduced the signal in the RNA assay, presumably by HIV RNA assay 113 competing with biotinylated capture probe for binding to the streptavidin-coated wells. Virus replication and HIV RNA accumulation proceeded to comparable levels during 3 days of culture in either biotin-rich or biotin-free medium.
Characterization of the nucleic acid target detected in infected cell Iysates
It WaS important to establish that only RNA was being detected by the capture and reporter probes, and that the assay was not detecting viral DNA also present in cell Iysates. To address this question, the nuclease susceptibility of the target detected in the assay format was characterized. Detection of an in vitro RNA transcript was eliminated largely by RNase treatment of the captured nucleic acid (2.2% resistant) while the same RNA target was insensitive to treatment with DNase I (107% resistant). Similarly, the signal detected from infected cell Iysates was sensitive to RNase treatment (2.6% resistant), while largely resistant (89%) to DNase treatment. These results suggested that the bulk of the nucleic acid detected in infected ceillysates was HIV RNA, rather than HIV DNA.
To determine whether the viral RNA detected after infection in microtitre plates was cell-associated or contained in extracellular virions, a time course experiment was performed in which cells and free virus were assayed independently. Cells and medium from eight microtitre plate wells were pooled, the cells pelleted by low-speed centrifugation, and virions concentrated from the supernatant medium by high-speed centrifugation. The HIV RNA content of each fraction was assayed using gag probes. As shown in Fig.4 , the viral RNA content of the initial virus inoculum was just detectable in the medium at the time of infection, but dropped below detectable limits by 5 h after infection. Cell associated viral RNA was first detected 48 h after infection. By 72 h, increased quantities of viral RNA had accumulated, both cell associated and as sedimentable particles in the culture medium. The majority of the detectable RNA (88%) was cell associated still although the quantity of virion RNA in the culture medium had increased significantly. As, in the usual microplate-based procedure most of the culture medium was removed before the sample was lysed, the RNA detected is almost completely cell associated.
Also examined was the effect of treatment of infected cell cultures with AZT, an effective inhibitor of HIV reverse transcriptase and consequently of HIV replication, at different times after infection. An inhibitory concentration of AZT (0.5 fl9 mr') was added to infected microplate wells at various times after infection and culture continued for 72 h. Treatment of the infected culture at or before 28 h post infection was effective at reducing the RNA signal Time after infection (h) for MTI dye reduction determined for each compound. From these data a TC 5 0 was determined. The relationship between the dose response curves for the MTI assay and the HIV RNA assay is shown in Fig. 5 for several compounds. For ddC, a licensed anti-HIV drug ( Fig.5a ), HIV RNA declined dramatically at low concentrations of ddC, while cell viability was well preserved in the cultures even at high concentrations of ddC. For XJ104, a experimental compound synthesized by DuPont Merck chemists, (Jadhav et al.,1992) , the MTI assay values declined somewhat more rapidly (TC 5 o of 1 ug ml") than did the HIV RNA levels (IC 5 o of 9 ug mr', IC gO of 30 ug rnr') ( Fig.5b ). For cyclohexamide (Figure 5c ), a general protein synthesis inhibitor, the MTI assay revealed a gradual reduction in cell viability and metabolism, while HIV RNA appeared to be affected more abruptly, with an ICgo of about 0.45 fl9 mt'. This is the same concentration that reduced readings in the MTI assay by 50% (TC 5 o ) . From a comparison of the MTI assay and HIV RNA assay dose-response curves for these and additional compounds, a practical rule was adopted requiring the ICgo for HIV RNA to be at least three-fold lower than the TC 5 0 in the MTI assay before a compound was considered to display any specific antiviral effect. Both patterns of non-specific toxicity were observed, i.e, MTI TC 5 0 equivalent to the RNA ICgo or MTI TC 5 0 less than the RNA ICgo, for multiple compounds, although the first pattern is more common. detected at 72 h (2%,5%,10%, and 18% of the level in untreated cultures when AZT was added at 4, 8, 20, or 28 h post infection) while treatment at 50 h had no effect on the level of RNA detected 72 h after infection. These results suggested that the majority of the viral RNA detected at 72 h was produced from viral DNA templates that became resistant to AZT inhibition sometime between 20 and 48 h after infection presumably because reverse transcription was complete. As progeny virus can be detected by 24 h after infection of MT-2 cells, these results suggested further that the bulk of the RNA-signal measured 72 h after infection in microtitre plates was produced from templates generated during subsequent cycles of HIV infection, rather than from cells infected by the input virus inoculum.
Discrimination between antiviral effects of compounds and non-specific toxic effects
To discriminate between specific antiviral effects and non specific toxic effects of compounds on host cells, an MTI dye reduction assay was used to quantify the number of metabolically active cells at the end of the incubation period. Cultures of compound-treated cells in microplates were grown without virus infection, and a dose response
Correlation between HIV RNA levels and yield of infectious virus
To validate use of this RNA quantitation assay as a tool for the rapid evaluation of the antiviral efficacy of compounds, correlation between the levels of HIV RNA and the yield of infectious virus accumulated in compoundtreated infections was examined. These comparisons were made in two ways. In the first experiment, cells were infected and cultured in the presence or absence of antiviral compounds. At the end of the culture period, cells were pelleted, lysed, and assayed for HIV RNA while a plaque assay for infectious HIV was carried out on the supernatant medium. As shown in Table 1 , there was a close correlation between the levels of HIV RNA in the infected cells and the amount of cell free infectious virus produced. Both cell-associated viral RNA and yield of infectious virus were reduced by treatment with AZT, a reverse transcriptase inhibitor, or P9941, an inhibitor of the HIV encoded protease (Jadhav et al., 1992) . The concentrations of antiviral compound required to inhibit either HIV RNA or yield of infectious virus by 50% or 90% ( IC 5 0 and ICgo) were very similar. As a second, more extensive comparison of the HIV RNA assay and the yield-reduction assay, the dose 
Utility of the HIV RNA assay for the detection of diverse virus strains in various eel/lines
MT-2 cells (5 x 1Q5cells ml-1) were infected in T-25 flasks with HIV RF at 2.0 or 0.5 TCID so per cell and cultured for 72 h in the presence or absence of antiviral compounds. At the indicated times, infected cell samples were collected by centrifugation and lysed in 5M GED for quantification of HIV RNA. Culture supernatants were assayed for titre of infectious virus by plaque assay on MT-2 cells. P9941 is an inhibitor of the HIV encoded aspartyl protease (Jadhav,1992) .
In this study the combination of highly susceptible MT-2 host cells and a rapid, high-level replicating strain of HIV-1 (strain RF) were used to develop a rapid assay for the response in each assay was determined independently for a variety of compounds, including known antiviral compounds of differing potencies. As IC go values were affected by the initial MOl, as shown in Table 1 , the virus inoculum used in the HIV RNA assay was standardized as described in Materials and Experimental procedures. As depicted in Fig. 6 , IC go values for active antiviral compounds determined by the two assays correlated well (R 2 = 0.76). Repeated determinations of the IC go value for a single antiviral compound made at different times were within three-fold of each other in the RNA assay. For 290 compounds evaluated in the two assay systems over several months, 90% of the ICgo values in the two different assays were within three-fold of each other or both assays scored the compounds as inactive. Of the independent/y determined IC go values in the two assays 95% were within five-fold of each other. In this comparison, evaluation of chemicals for antiviral potency. However, the HIV RNA assay can be used also to detect HIV RNA gag and pol sequences of other strains of HIV as well as the replication of virus in other types of host cells. When HIV-1(RF) virus was used to infect three established Tcell lines (MT-2, GEM and H9), MT-2 cells accumulated the highest level of HIV RNA during a 3-day culture period, but HIV RNA could be detected also 3 days after infection of GEM cells or H9 cells. H9 cells accumulated the lowest level of RNA, but this level was still 30 times the background level measured in the RNA assay from uninfected cells (signal/noise = 30) after infection with a 1:2 dilution of the virus stock. With adjustments in the length of the culture period after infection, or by processing larger cell samples, detection of HIV RNA after growth in other established T-cell lines, or other cell types seems feasible. Both the gag and pol probe sets recognize strains of HIV also besides the RF strain. Two other laboratory strains (1I1B and MN) were detected readily following replication in MT-2 cells. It was also possible to detect HIV RNA after infection of MT-2 cells in microtitre plates with four different clinical isolates of HIV. For one slow growing isolate, HIV gag RNA was measured 6 days, rather than 3 days, after infection in microtitre plates.
Discussion
The assay method described provides a simple, microtitre plate-based, non-radioactive method for quantifying HIV gag and pol RNA sequences in crude cell Iysates. Hybridization to capture probes in high concentrations of guanidinium isothiocyanate followed by dilution to lower guanidinium isothiocyanate concentrations compatible with biotin-streptavidin binding protects HIV RNA targets from degradation in crude cell Iysates. Immobilization of hybridized HIV RNA allows simple purification from other cell components during washing, and allows hybridization with reporter probes which would be inactivated by direct exposure to high concentrations of guanidinium isothlocyanate. This method is useful especially for comparing the relative concentrations of HIV RNA in multiple samples as sample preparation is minimal. Both virus culture arid quantification are performed in microtitre plates, facilitating the use of pipetting workstations and the handling of a large number of samples. HIV RNA rather than DNA is the major nucleic acid target detected in Iysates of infected cells. Selectivity of the assay for RNA probably reflects the relative quantities of viral RNA and DNA present in acutely infected cells and may be enhanced by the absence of denaturing steps during the sample lysis which would be required to make double-stranded DNA available for hybridization. Both gag and pol probes can be used to detect and quantify HIV RNA, although the signal generated using gag" probes is greater. Both sets of probes measure an equal quantity of HIV RNA in Iysates of infected cells. Indeed, IG 9 0 values for antiviral compounds are the same using either gag or pol probes. Such equivalence of gag and pol probes might be expected, given the presence of both sequences on the same RNA transcript in infected cells. Because of their greater sensitivity, the gag probes were used for the majority of compound evaluations.
Using gag probes, the limit of sensitivity (S/N >2.0) of the RNA assay in the presence of cell lysate is approximately 0.3 ng of pDAB 72 in vitro RNA transcript. This corresponds to about 5 x 10 7 copies of this model RNA target. Infections of MT-2 cells in a single microtitre-plate well with the RF strain of virus result typically in a signal equivalent to that generated by 10-15 ng of pDAB 72 in vitro RNA transcript. If natural HIV gag-pol RNA is recognized as a target with the same efficiency as the shorter rnodel in vitro RNA transcript, this would correspond to 2-3 x 10 9 copies of HIV RNA per well. Since 1 x 10 5 MT-2 cells are added to each well before infection, this value suggests that 2 x 10 4-3 x 10 4 copies of HIV gag-pol RNA are accumulated per cell. Although it is quite high this level of viral RNA accumulation is not beyond the range of levels reported in other studies. Accurnulation of HIV RNA appears to proceed to especially high levels in certain HTLV-1-transformed, acutely sensitive cell lines such as G8166 cells Robinson, 1988, Robinson and Somasundaran, 1990) . While Somasundaran and Robinson (1988) did not report on HIV RNA levels in the MT-2 cell line, these cells are similar to the G8166 cell line in that both are HTLV-1 transformed T cell lines which are highly susceptible to HIV infection, syncytia formation, and cell killing. In G8166 cells, 4 x 10 4 copies of HIV RNA per cell were measured 2 days after infection with HTLV-IIIB at an MOl:::: 0.2, consistent with the RNA levels observed 2-3 days after infection of MT-2 cells with the RF strain of HIV. Other cell lines may accumulate lower levels of viral RNA. Pellegrino et al. (1991) reported HIV pol RNA levels of 5000 copies per cell 5 days following infection of H9 cells, while Gillespie et al. (1989) measured 2200 copies of HIV RNA 6 days following infection of H9 cells.
A consistent difference was observed in the shape of the dose response curve generated when HIV replication was inhibited by compounds with different modes of action (Fig. 7) . When reverse transcriptase inhibitors such as AZT or ddG were tested, levels of HIV RNA in infected cell cultures were reduced to undetectable levels at high concentrations of inhibitor. In contrast, when compounds which act by inhibition of the HIV-encoded protease were tested a plateau level of RNA, representing 2-10% of the RNA accumulated in an untreated infection, was observed at high inhibitor concentration. This protease spliced rnessaqes encoding small regulatory proteins such as rev and tat (Kim et al., 1989) . Detection of RNA sequences, rather than the DNA provirus from which they arise, tests for active expression of the viral genO;me and takes advantage of the amplified number of RNA transcripts which are generated from the limited number of proviral DNA copies produced per cell. While detection and quantification of proviral DNA copies has been used to monitor replication of HIV in PBMC cultures (Eron et et., 1992) , the limited number of DNA copies generated following HIV infection required the use of PCR amplification methods to generate detectable signals from the infected cell samples. A major advantage of the described method for quantitating natural HIV gag-pol transcripts is that PCR or other nucleic acid amplification techniques are not required. As a result, quantification of the levels of viral RNA is more direct, requires fewer steps, and need not be subject to the precautions required to avoid cross contamination during nucleic acid amplification techniques. Quantification of viral RNA provides a more direct measure of viral replication than measurement of the indirect cytopathic effects of virus replication orr host cells (Mitsuya and Broder, 1986; Pauwels et al., 1988) The mechanisms mediating virally induced cytopathic effects on host cells often are unclear, and how these effects will be influenced by the addition of antiviral and/or toxic compounds is sometimes unpredictable.
Two protein products of HIV replication, the reverse transcriptase enzyme, and p24 gag antigen, have been used frequently as markers of HIV replication in infectivity assays. While usually diagnostic of authentic virus production, measurements of reverse transcriptase activity are labour intensive, relatively insensitive, and make use of radioactive substrates. The HIV RNA assay offers a non-radioactive assay format, simple sample preparation, and high capacity, as all steps are performed in microtitre plates. Several commercial ELISA kits are available for the detection of HIV-1 p24 gag antigen. Detection of p24 antigen using these kits is very sensitive, with detection limits of 10-200 pg mr'. In practice, this extreme sensitivity frequently is a disadvantage, requiring multiple assays at different dilutions to bring test samples within the dynamic range of the ELISA. In addition, the initial virus innoculum almost always contains readily detectable quantities of p24 antigen, requiring either that cultures be washed free of input virus after an initial adsorption period, or that the antigen from the initial innoculum remain, reducing the certainty with which p24 antigen detected at the end of the replication period can be ascribed to virus replication. In contrast, the levels of viral RNA accumulated during the 3-day infection period fall within the dynamic range of the HIV RNA assay and the initial virus innoculum does not generate a significant signal in the absence of virus replication. .,r-",,","","""""""""""""'-""""",..,.,.,.j 0.01 inhibitor insensitive RNA is distinct from the RNA associated with the initial virus inoculum in that it is cell associated and represents also significantly more copies of RNA than detected in the initial virus inoculum. It is suggested that this plateau represents HIV RNA synthesized from cells infected by the initial virus inoculum. Treatment with an effective protease inhibitor, which might be expected to act at a late stage in the virus life cycle after the generation of viral RNA transcripts would not be expected to affect this initial round of infection (Jacobsen et el., 1992) . Virions produced in the presence of HIV protease inhibitors are non-infectious (McQuade et el., 1990) and RNA signal which depends on secondary infection by these progeny virions would be sensitive to inhibition by an effective protease inhibitor. In contrast, reverse transcriptase inhibitors would be expected to inhibit even the first round of virus replication prior to the transcription of any viral RNA, and thus should be capable of reducing viral RNA to undetectable levels. The characteristic difference in the shape of the dose response curve generated in the RNA assay may be a useful first indication of the time of action (before or after the generation of viral RNA transcripts) of inhibitors of unknown mechanism of action.
HIV gag and pol RNA sequences represent attractive markers of virus replication. These RNA sequences represent a relatively late product of virus infection. Virus binding, entry, and uncoating, as well as reverse transcription and integration must occur before transcription of viral RNA species from the integrated DNA provirus of HIV. Among viral mRNA species, it has been reported that gag-pol sequences appear later than the multiply Thus, 40-50 compounds can be evaluated for antiviral efficacy at once and, by using the MTI assay in parallel, for toxicity during a four day period. Although the HIV RNA assay was used to quantitatively measure the antiviral potency and toxicity of a variety of compounds, this assay format is well suited also to initial screening of a larger number of chemicals for antiviral activity. By testing each compound at two concentrations, in duplicate, 640-800 compounds could be screened for both antiviral activity and toxicity, in the same 8-10 microplates per
week. The method described should be applicable to the detection and quantification of RNA of other viruses, and could form the basis of similar high capacity assays for antiviral potency.
Materials and Experimental procedures
DNA Plasmids and in vitro RNA transcripts
Plasmid pDAB 72 containing both gag and pol sequences of BH10 (b.p. 113-1816) cloned into PTZ 19R was the kind gift of S. Erickson-Viitanen (Erickson-Viitanen at al., 1989) . The plasmid was linearized with Bam HI prior to the generation of in vitro RNA transcripts using the Riboprobe Gemini system II kit (Promega, Madison, WI) with T7 RNA polymerase. Synthesized RNA was purified by treatment with RNase free DNAse (Promega), phenol-chloroform extraction, and ethanol precipitation. RNA transcripts were dissolved in water, and stored at -70°C. The concentration of RNA was determined from the A 2 6 0 .
Probes
Biotinylated capture probes were purified by HPLC after synthesis on an Applied Biosystems (Foster City, CA) DNA synthesizer by addition of biotin to the 5' terminal end of the oligonucleotide, using the biotin-phosphoramidite reagent of Cocuzza (1989) The gag biotinylated capture probe (5-biotin-CTAGCTCCCTGCTIGCCCATACTA-3') was complementary to nucleotides 889-912 of HXB2 and the pol biotinylated capture probe (5'-biotin-CCCTATCATTITIGGTITCCAT-3') was complementary to nucleotides 2374-2395 of HXB2. Alkaline phosphatase conjugated oligonucleotides used as reporter probes were prepared by Syngene (San Diego, CA.). The pol reporter probe (5'-CTGTCTIACTITGATAAAACCTC-3') was complementary to nucleotides 2403-2425 of HXB2. The gag reporter probe (5'-CCCAGTATTIGTCTACAGCCTICT-3') was complementary to nucleotides 950-973 of HXB2. All nucleotide positions are those of the GenBank Genetic Sequence Data Bank as accessed through the Genetics Computer Group Sequence Analysis Software Package (Devereau at al.,1984) . The reporter probes were prepared as 0.5 flM stocks in 2 x SSC (0.3 M NaCl, 0.03 M sodium citrate), 0.05 M Tris pH 8.8, 1 mg ml-1 BSA. The biotinylated capture probes were prepared as 100 flM stocks in water.
Streptavidin coated plates
Nunc-immunomodule microtitre plate strips were coated by addition of 200 fll of streptavidin (30 fl9 rnr", Scripps, La Jolla, CA) in freshly prepared 10 mM sodium carbonate (pH 9.6). Plates were incubated overnight at 4°C. Streptavidin solution was aspirated from the wells and a blocking buffer composed of phosphate buffered saline (PBS), 20 mg ml-1 bovine serum albumin (crystalline, nuclease and protease free, Calbiochem ) and 100 mg mr" lactose (Sigma Chemical Co., St. Louis, MO) was added to the plates for 3 h at room temperature. Blocking buffer was removed from the wells, which were allowed to dry overnight at room temperature and SUbsequently stored at 4°C in zip lock bags with desiccant. For the majority of the compound evaluation experiments, streptavidin coated plates were obtained from Du Pont Biotechnology Systems (Boston, MA.)
Cells and virus stocks
MT-2, CEM, and H9 cells were maintained in RPMI1640 supplemented with 5% fetal calf serum (FCS), 2mM L-glutamine and 50 fl9 ml-1 gentamycin, all from Gibco (Grand Island, NY).
Laboratory strains of HIV-1 (RF, MN and IIlB) were propagated in H9 cells in the same medium. Virus stocks were prepared approximately 1 month after acute infection of H9 cells by clarification of the tissue culture medium and storage of aliquots at -70°C. Infectious titres of HIV-1(RF) stocks were 1-3 x 10 7 plaque forming units (p.t.u.) mr' as measured by plaque assay on MT-2 cells (see below). Each aliquot of virus stock used for infection was thawed only once. In some cases, infected H9 cells were shifted to Dulbecco's modified Eagle's medium 3-10 days before collection of virus in order to generate virus stocks in medium with low biotin content. Clinical isolates of HIV that had been passaged once in MT-2 cells were used to infect fresh MT-2 cells in RPMI medium. Three days after infection, cells were pelleted, resuspended and culture continued in Dulbecco's modified Eagles medium as above. Virus stocks of clinical isolates were prepared 10-15 days after infection when cytopathic effects were apparent in the culture. For evaluation of antiviral efficacy, cells to be infected were subcultured 1 day prior to infection. On the day of infection, cells were resuspended at 5 x 10 5 cells mr" in RPM11640, 5% FCS for bulk infections or at 2 x 10 6 mr' in either Dulbecco's modified Eagle's medium, or RPMI 1640 medium minus biotin (Gibco, custom formulation) with 5% FCS for infection in microtitre plates. Virus was added and culture continued for 3 days at 37°C. In some experiments, virus was removed after an initial adsorption period.
Preparation of HIV-1 infected celllysates
HIV-1 infected cells were pelleted by centrifugation. After removal of the supernatant the cells were resuspended at a concentration of 1 x 10 7 cells ml-1 in 5 M guanidinium isothiocyanate solution (GED: 5M guanidinium isothiocyanate [Sigmaj, 0.1 M EDTA, 10% dextran sulfate), Alternately, cells grown in biotin free tissue culture medium were mixed with 5 M GED to a final concentration of 3 M guanidinium isothiocyanate, 0.06M EDTA, and 6% dextran sulfate.
HIV RNA assay
Ceillysates or purified RNA !Ii 3 or 5 M GED were mixed with 5M GED and capture probe to a final guanidinium isothiocyanate concentration of 3M and a final biotin oligonucleotide concentration of 30 nM. Hybridization was carried out in sealed microfuge tubes or in sealed U bottom 96 well tissue culture plates (Nunc, Roskilde, Denmark or Costar, Cambridge, MA) for 16~20h at 3JOC. RNA hybridization reactions were diluted three fold with deionized water to a final guanidinium isothiocyanate concentration of 1 M and aliquots (150 Ill) were transferred to streptavidin-coated microtitre plate wells. Binding of capture probe and capture probe-RNA hybrid to the immobilized streptavidin was allowed to proceed for 2 h at room temperature, after which the plates were washed six times with DuPont ELISA-plate wash buffer (phosphate buffered saline [PBSj, 0.05% Tween 20.) A second h.,y'bridization of reporter probe to the immobilized complex 'of capture probe and hybridized target RNA was carried out in the washed strepta-: vidin-coated well by addition of 120 III of a hybridization cocktail containing 4 x SSC, 0.66% Triton x 100, 6.66% deionized formam ide, 1 mg mr" BSA and 5 nM reporter probe. After hybridization for 1 h at 3JOC, the plate was washed again 6 times. Immobilized alkaline phosphatase activity was detected by addition of 100 III of 0.2 mM 4-methylumbelliferyl phosphate (MUBP, JBL Scientific, San Luis Obispo, CA) in buffer D (2.5 M diethanolamine pH 8.9 [JBLj, 10 mM MgCI 2 , 5mM zinc acetate dihydrate and 5 mM N-hydroxyethyl-ethylene-diamine-triacetic acid). The plates were incubated at 37°C. Fluorescence at 450 nM was measured using a microplate fluorometer (Dynateck, Chantilly, VA) exciting at 365 nM. S designates the signal measured in wells which received samples while N designates the signal measured in wells which received GED rather than sample, but all other components of the hybridization solutions and alkaline phosphatase substrate solution.
Nuclease susceptibility of nucleic acid target detected in infected cell tysetes
PDAB 72 in vitro RNA transcripts or infected cell Iysates were prepared 3 days after infection of MT-2 cells with HIV RF or were hybridized with gag capture probe, diluted, and bound to streptavidin coated microtitre plates as described. After washing, solutions containing either 10 Ilg ml-1 pancreatic RNAse A (Sigma) in 0.15M NaCI, 0.05M Tris pH7.5, 0.01 M EDTA or 25 u ml-1 R01 DNAse (Promega) in 0.15 M NaCI, 0.05 M Tris pH 7.5, 0.01 M MgCI 2 , 0.002 M DTT pius 100 U rnr' RNasin (Promega) were added to separate wells and incubated for 30 min at 37°C. After washing, hybridization with alkaline phosphatase reporter probe, washing, and detection with MUBP was as described. Percent resistance is calculated relative to the signal generated in wells treated with each of the nuclease digestion buffers in the absence of added enzyme.
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HIV yield reduction assay
This assay was conducted as described previously (Smallheer et el., 1992) . Test compounds were dissolved in dimethylsulfoxide (DMSO) to 5 mg mF-1 and serially diluted into RPMI medium to 10 times the desired final concentration. MT-2 cells were mixed with the appropriate test compound solution and allowed to incubate for 30 min at room temperature. Virus was added to the cell and compound mixtures and incubated for 1 h at 36°C. The mixtures were centrifuged and the supernatants containing unattached virus were discarded. The cell pellets were suspended in fresh medium containing the appropriate concentrations of test compound. Virus was allowed to replicate for 3 days. Cultures were centrifuged and the supernatants containing cell free progeny virus were removed for plaque assay. The antiviral activity of test compounds was determined by the per cent reduction in virus titre with respect to virus grown in the absence of inhibitors.
Compounds
Dideoxycytidine (ddC) and cyclohexamide were obtained from Sigma. Azidothymidine (AZT) was obtained from J. Blasecki, DuPont Merck Pharmaceutical Company (WilmIngton, DE. P9941 (2S,3R,4R,5S)-N,N'-Bis ([2-pyridylacetylj-L-isoleucinyl)-2,5-diamino-1,6-diphenylhexane-3,4-diol, 08024 (2S,3R,4R,5S)-N,N'-Bis ([benzyloxycarbonylj-L-valinyl)-2,5-diamino-1 ,6diphenylhexane-3,4-diol, and XJ104 (2R,3R,4R,5S)-N,N'-Bis ([t-butoxycarbonylj-L-valinyl)-2,5-diamino-1 ,6-diphenylhexane-3,4-diol (triphenylphosphine adduct) were synthesized as described (Jadhav et al., 1992) . Additional antiviral compounds tested in Fig. 6 were synthesized as part of the Du Pont Merck HIV antivirals discovery programme.
Microplate-based compound evaluation in HIV-1 infected MT-2cells
Compounds to be evaluated were dissolved in DMSO and diluted in culture medium to twice the highest concentration to be tested and a maximum DMSO concentration of 2%. Further three-fold serial dilutions of the compound in culture medium were performed directly in U-bottom microtitre plates (Nunc). After compound dilution, MT-2 cells (50 Ill) were added to a final concentration of 5 x 10 5 mr" (1 x 10 5 per well). Cells were incubated with compounds for 30 min at 37°C in a CO 2 incubator. For evaluation of antiviral potency, an appropriate dilution of HIV-1 (RF) virus stock (50 Ill) was added to culture wells containing cells and dilutions of the test compounds. The final volume in each well was 200 Ill. Eight wells per plate were left uninfected with 50 III of medium added in place of virus, while eight wells were infected in the absence of any antiviral compound. For evaluation of compound toxicity, parallel plates were cultured without virus infection.
After 3 days of culture at 3JOC in a humidified chamber inside a CO 2 incubator, all but 25 III of medium per well was removed from the HIV-infected plates. Thirty-seven microlitres of 5 MGED containing biotinylated capture probe was added to the settled cells and remaining medium in each well to a final concentration of 3M GED and 30 nM capture probe. Hybridiza-tion of the capture probe to HIV RNA in the cell lysate was carried out in the same microplate well used for virus culture by sealing the plate with a plate sealer (Costar), and incubating for 16-20 h in a 37°C incubator. Then distilled water was added to each well to dilute the hybridization reaction three fold and 150 III of this diluted mixture was transferred to a streptavidincoated microtitre plate. HIV RNA was quantified as described above. A standard curve, prepared by adding known amounts of pDAB 72 in vitro RNA transcript to wells containing lysed uninfected cells, was run on each microtitre plate in order to determine the amount of viral RNA made during the infection.
In order to standardize the virus inoculum used in the evaluation of compounds for antiviral activity, dilutions of virus were selected which resulted in an IC go value (concentration of compound required to reduce the HIV RNA level by 90%) for dideoxycytidine (ddC) of 0.2 ug mr'. IC g o values of other antiviral compounds, both more and less potent than ddC, were reproducible using several stocks of HIV-1 (RF) when this procedure was followed. This concentration of virus corresponded to -3 x 10 5 p.f.u. (measured by plaque assay on MT-2 cells) per assay well and typically produced approximately 75% of the maximum viral RNA level achievable at any virus inoculum. For the HIV RNA assay, IC g o values were determined from the per cent reduction of net signal (signal from infected cell samples minus signal from uninfected cell samples) in the RNA assay relative to the net signal from infected, untreated cells on the same culture plate (average of eight wells). Valid performance of individual infection and RNA assay tests was judged according to three criteria. The virus infection was required to result in an RNA assay signal equal to or greater than the signal generated from 2 ng of pDAB 72 in vitro RNA transcript. The IC g O for ddC, determined in each assay run, was required to be between 0.1 and 0.3 ug rnl' and the plateau level of viral RNA produced by an effective protease inhibitor was required to be less than 10% of the level achieved in an uninhibited infection.
In order to assess the potential cytotoxicity of compounds being evaluated for antiviral efficacy, an MTT dye reduction assay (Mosmann, 1983 , Alley et al.,1986 was performed on cells incubated with compounds in the absence of virus. Conditions of culture and time of incubation were identical to those used for infected cells. At the end of the culture period, 10 III of MTT (3-[4,5-dimethylthaizol-2"yl]-2,5diphenyl tetrazolium bromide, Sigma, 5 mg mr' in PBS) were added to each microplate well and incubation at 3rC continued for 2 h in a CO 2 incubator. Then 150 III of the supernatant medium was removed from each well. Reduced MTT dye was solubilized by addition of 200 III of 0.04 N HCI in isopropanol and rnixinq. Solubilized MTT dye product was quantified using an ELISA reader at 570 nM. Results of the cytotoxicity determinations are expressed as 50% toxic levels (TC 5 0 ) defined as the level of compound which reduced the signal from compound treated cells by 50% compared to untreated, uninfected control cultures.
For both toxicity and antiviral potency tests, all manipulations in microtitre plates, following the initial addition of 2X-concentrated compound solution to a single row of wells, were performed using a Perkin Elmer/Cetus (Norwalk, CT) ProPette. Data from the MTT assay and the HIV RNA assay were transferred directly to a MICROSOFT EXCEL™ spreadsheet on a Mac" intosh personal computer.
